Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells.
Small molecule ruthenium complexes show great promise as anticancer pharmaceuticals, but further rational development of these as drugs is stymied by an incomplete understanding of the mechanisms that give rise to markedly different biological behaviour for structurally similar species. X-ray fluorescence imaging at two incident energies was used to reveal the intracellular distribution of Ru in single human cells treated with KP1019, showing Ru localised in both cytosol and in the nuclear region. In addition the imaging showed that treatment with KP1019 modulated Fe distribution to resemble the Ru distribution, without affecting cellular Fe content. In stark contrast, Ru could not be visualised in cells treated with NAMI-A, indicating that it was not internalised and supporting the proposition that its activity is exerted through a membrane-binding mechanism.
School of Chemistry, The University of Sydney, New South Wales 2006, Australia.
Jade B
JB
Aitken
Sumy
S
Antony
Claire M
CM
Weekley
Barry
B
Lai
Leone
L
Spiccia
Hugh H
HH
Harris
D045744:Cell Line, Tumor; D004121:Dimethyl Sulfoxide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D007191:Indazoles / Q000493:pharmacokinetics*; D042541:Intracellular Space / Q000737:chemistry / Q000378:metabolism*; D007501:Iron / Q000378:metabolism; D057054:Molecular Imaging; D009942:Organometallic Compounds / Q000493:pharmacokinetics*; D017975:Ruthenium Compounds; D059010:Single-Cell Analysis / Q000379:methods*; D013052:Spectrometry, X-Ray Emission / Q000379:methods*
D007191:Indazoles; D009942:Organometallic Compounds; D017975:Ruthenium Compounds; C113661:imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III); C499292:indazolium trans-(tetrachlorobis(1H-indazole)ruthenate (III)); D007501:Iron; D004121:Dimethyl Sulfoxide